ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1143

Gout and Renal Failure-Related Mortality Trends in USA from 1999-2020: Analysis of CDC Wonder Database

Shiamak Cooper1, Sanjana Thimmannagari2, Ranjini Vengilote2 and Asim Khanfar2, 1Rochester General Hospital, Irondequoit, NY, 2Rochester General Hospital, Rochester, NY

Meeting: ACR Convergence 2025

Keywords: gout, Mortality, quality of care, race/ethnicity, Renal

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1123–1146) Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Gout is the most common form of inflammatory arthropathy, with a prevalence ranging from 0.1% to approximately 10% worldwide. Despite a well-established association between gout and renal disease, the real-world data on the mortality rate due to renal disease or failure in patients with gout is not well established. Hence, we aim to assess the longitudinal trends in mortality rates attributed to renal disease in patients with gout. In addition, we aim to analyse for disparities in regard to race, sex, and geographical location in the United States.

Methods: Age-adjusted mortality rates (AAMR) per 100,000 individuals were obtained from the Centers of Disease Control and Prevention WONDER database from the years of 1999-2020. Joinpoint regression was applied to calculate the annual percentage change (APC) to evaluate significant differences in the change of AAMR over time.

Results: A total of 9263 deaths due to renal failure occurred in patients with Gout from 1999 to 2020. The AAMR from 1999 to 2012 insignificantly increased (APC 1.31) and sharply declined from 2012 to 2020 (APC -34.96). The same trend was reflected when stratified for females and males. The AAMR in urban areas had a trivial decline from 1999 to 2012 (APC 0.86) whereas significantly declined from 2012 to 2015 (APC -34.48). In rural areas, the AAMR initially significantly increased from 1999 to 2005 (APC 10.13), then decreased from 2005 to 2012 (APC -0.66) and subsequently significantly reduced from 2012 to 2015 (APC -32.79). The absolute AAMR for African Americans as compared to Whites were significantly different from 1999 to 2012. From 2012 to 2015, both subgroups had a statistically significant decline in AAMR, African Americans (APC -43.38 [-54.92, -21.89]) and Whites (APC -30.62 [-38.73, -3.42]). From 2015-2020, the AAMR remained fairly stable and similar in absolute numbers for both subgroups.

Conclusion: From 1999 to 2012, renal failure-related mortality in gout patients initially increased but had a significant drop from 2012 to 2015. Mortality rates reflected similarly in both sexes, females and males. Rural areas had an initial increase in mortality as compared to urban areas from 1999 to 2005. Blacks had a higher absolute mortality as compared to Whites until 2012 after which there was a sharp decline to similar rates from 2012 to 2015. These potential disparities warrant further research into quality of care delivered and phenotype of disease based on race and rural status. In addition, these findings may point towards improvement and standardization of care amongst different races and geographical areas after the introduction of the American College of Rheumatology (ACR) 2012 Gout guidelines.

Supporting image 1Annual Percentage Change in Gout and Renal Failure-Related Mortality by Year and Gender

Supporting image 2Annual Percentage Change in Gout and Renal Failure-Related Mortality by Year and Race

Supporting image 3Annual Percentage Change in Gout and Renal Failure-Related Mortality by Year and Urban-Rural


Disclosures: S. Cooper: None; S. Thimmannagari: None; R. Vengilote: None; A. Khanfar: None.

To cite this abstract in AMA style:

Cooper S, Thimmannagari S, Vengilote R, Khanfar A. Gout and Renal Failure-Related Mortality Trends in USA from 1999-2020: Analysis of CDC Wonder Database [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/gout-and-renal-failure-related-mortality-trends-in-usa-from-1999-2020-analysis-of-cdc-wonder-database/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gout-and-renal-failure-related-mortality-trends-in-usa-from-1999-2020-analysis-of-cdc-wonder-database/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology